Targeting HASPIN-mediated H3T3 phosphorylation disrupts an epigenetic-kinesin axis to suppress colorectal cancer
Tong Wu1, Yaguang Zhang1, Sicheng Liu1
1Laboratory of Gastrointestinal Tumor Epigenetics and Genomics, State Key Laboratory of Biotherapy and Cancer Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, P.R. China.
Abstract:
Chemoresistance remains a major barrier in colorectal cancer (CRC) therapy. Through epigenetic compound screening in patient-derived organoids (PDOs), we identified CX6258.HCl as a potent growth inhibitor. Treatment with CX6258.HCl significantly inhibited cell mitosis and induced apoptosis in CRC cell lines. Mechanistically, CX6258.HCl binds the D687 residue within HASPIN's kinase domain, suppressing H3T3 phosphorylation (H3T3ph). This triggers an epigenetic cascade: loss of H3T3ph upregulates demethylase KDM5B pre-mRNA, depleting H3K4me3 at promoters of Kinesin family member (KIFC1/KIF10/KIF14). Consequently, microtubule dynamics are disrupted, leading to mitotic arrest. Target specificity was validated genetically via HASPIN-D687A mutation. In vivo, CX6258.HCl suppressed CRC xenograft growth and further enhanced 5-FU-mediated tumor suppression without obvious histological injury in major organs. Clinically, elevated H3T3ph levels in human CRC tissues were associated with Ki67-positive proliferative tumor regions, suggesting that H3T3ph may represent a proliferation-associated marker in CRC. Together, our findings identify the HASPIN/H3T3ph-KDM5B-H3K4me3-KIF axis as a targetable antimitotic pathway and support therapeutic inhibition of HASPIN/H3T3ph as a potential strategy for CRC.
Insights
A new drug, CX6258.HCl, effectively inhibits colorectal cancer (CRC) growth by targeting the HASPIN pathway. This epigenetic approach suppresses mitosis and enhances chemotherapy, offering a promising new strategy for CRC treatment.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Chemoresistance is a significant challenge in colorectal cancer (CRC) treatment.
- Epigenetic modifications play a crucial role in cancer progression and drug resistance.
Purpose of the Study:
- To identify novel therapeutic targets and agents for colorectal cancer (CRC) by screening epigenetic compounds.
- To investigate the mechanism of action of CX6258.HCl in inhibiting CRC growth and overcoming chemoresistance.
Main Methods:
- Screening of epigenetic compounds using patient-derived organoids (PDOs).
- In vitro studies on CRC cell lines to assess cytotoxicity, apoptosis, and cell cycle effects.
- Mechanistic studies involving protein binding assays, Western blotting, and genetic validation (HASPIN-D687A mutation).
- In vivo studies using CRC xenograft models and combination therapy with 5-FU.
- Clinical correlation analysis of H3T3ph levels in human CRC tissues.
Main Results:
- CX6258.HCl identified as a potent inhibitor of CRC cell growth, inducing apoptosis and mitotic arrest.
- CX6258.HCl targets HASPIN at the D687 residue, suppressing H3T3 phosphorylation (H3T3ph).
- This leads to KDM5B upregulation, H3K4me3 depletion, and disruption of microtubule dynamics via KIFs.
- CX6258.HCl demonstrated efficacy in vivo, suppressing xenograft growth and potentiating 5-FU therapy.
- Elevated H3T3ph levels correlate with tumor proliferation (Ki67) in human CRC.
Conclusions:
- The HASPIN/H3T3ph-KDM5B-H3K4me3-KIF axis represents a novel, targetable antimitotic pathway in CRC.
- Therapeutic inhibition of HASPIN/H3T3ph is a potential strategy for overcoming CRC chemoresistance.
- H3T3ph may serve as a predictive biomarker for tumor proliferation in CRC.
Related Concept Videos
Destabilization of Microtubules
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Anaphase Promoting Complex
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...

